In recent years, many scientific research institutions in the United States and even Europe have become very popular to open scientific research institutes in China, because for them, China's abundant human resources are very important. Pen? Interesting? Pavilion wWw. ｂiquge。 ｉｎfo

Especially in the past decade or so, the frantic expansion of Chinese universities has provided abundant human resources to all scientific research institutions in the world.

Although the popularity of electronic computers in the world is very high, which is a good thing for scientific research institutions, there are some scientific experiments that cannot be simulated by computers, and people are still needed to do such experiments.

Such experiments must be completed by educated high-level bachelor-level talents, and in Europe and the United States, the labor cost of hiring such scientific research talents is very high.

For example, in the United States, if a laboratory hires a basic scientific research talent, that is, the bottom of the laboratory, who specializes in experiments and data collection, even if the other party is a recent college graduate, his salary will start at least $80,000.

In Europe, the salary may be a little higher, and although European and American college students are imaginative, they are also notoriously loose and inefficient, so that they sit in the laboratory every day, doing hundreds of experiments, many people may not be able to persevere, sometimes in a month, their entire experimental progress, maybe only 20%.

In addition, if you hire them, you can't easily fire them, and you can't easily give orders to them, there is no way who will let us in Europe and the United States be civilized societies, if you push them too hard, people will sue you, how can the scientific research institute have the time and energy to fight with these people?

So even if you are not satisfied with the work of the following people, you can only endure it, and if you take these basic data to China, it will be much easier.

Chinese are known for their hard work, and even if you give them more tasks, they will find a way to complete them for you within the stipulated time.

In addition, although these Chinese have poor innovation ability, but the basic knowledge is very solid, you must know that China is famous for the kingdom of arithmetic, where college students have a very solid mathematical foundation, which is very beneficial to scientific experiments.

And the most important point is that their labor cost will be very low, you need to hire a basic experimenter in the United States, it also costs 80,000 US dollars, but in China, you only need to spend 80,000 yuan, even if it is a high-level management talent, it is only about 200,000 yuan a year, and the labor cost is only one-third of that in the United States.

This is a very good thing for scientific research institutes, which are already short of funds.

In addition, the cost of doing scientific experiments in China is also very low, first of all, the cost of consumables is low, and then the requirements for environmental pollution are also low, which is of great benefit to the investment of the laboratory.

Another point is that there is a time difference between China and Europe and the United States, basically the United States is at night, and China is daytime, so the United States can assign tasks to the Chinese side before getting off work, and when they go to work the next morning, they can get the pressure data fed back from the Chinese side, so as to achieve seamless connection in the work and greatly improve the efficiency of the work, which is very important to the American scientific research institutes.

Therefore, basically in the United States, store-sized scientific research units will set up a laboratory branch in China, which can handle the most basic and simple scientific experiments and collect data, and the results are very good.

If it weren't for the shortage of funds, Scott would have opened such a branch of a scientific research institute in China a long time ago, and he was already very happy when Jin Muchen promised him, but at that time he thought that such a branch would take at least a year to build.

But now that the institute has introduced a new strategic shareholder, it seems that it will greatly speed up the construction of their branch test institution.

According to Jin Muchen, he is a large real estate developer in China, with countless land and houses in his hands, and he can find a set to renovate for himself, which is enough for his own use.

The most important point is that other people's real estate property rights will be given to him, my God, although he is not a professional in the financial field, but now he also knows how hot real estate is in China's major first-tier cities, where a random house costs millions of dollars.

Such a big scientific research institution... Why do you have to occupy hundreds of square meters? How much money is paid, just having such a set of properties is enough for the scientific research institute to be proud.

If you really can't do it at that time, you can sell that piece of land, and you can make a lot of money.

In addition, this land and branches are not counted, so Mr. Wang has to give himself 10 million US dollars for nothing, looking at Jin Muchen's meaning, he does not plan to dilute his shares, so this 10 million is all his own, this money, he can spend it as he wants?

Wow Ka Ka, then you have money, you have to know that you have been engaged in scientific research for so many years, although you don't particularly value money, but who doesn't want to live the addiction of millionaires and multimillionaires?

What's more, now is the time when he is most short of money? With this money, he Scott can afford the best lawyer, fight a lawsuit against his ex-wife, and then take back custody of his two children.

After all, in terms of economic strength, he is much more powerful than his unconscionable ex-wife.

As soon as he thought of this, Scott suddenly felt in a better mood, his breath was smoother, his waist no longer hurt, his legs were not sore, and he was walking energetically.

Suddenly, he seemed to remember something again, and then turned his head to Jin Muchen and said, "Muchen, two days ago, you asked me if I knew that there are some small and medium-sized pharmaceutical companies in the United States that want to be sold, right?" ”

"yes, why did you get any useful news?"

Hearing Scott's question, Jin Muchen's eyes suddenly lit up, since listening to Wang Xueming's thoughts yesterday, he has been thinking about the unicorn company, how to think about it, how to think it is reliable.

However, the key to the operation of this insight is that they must first have a reliable pharmaceutical company in their hands, but now it seems that domestic pharmaceutical companies basically do not meet their requirements, which needs to be found abroad.

And such a company is the most reliable to look for in the United States, because he took a look at the situation of pharmaceutical companies in Europe yesterday, and the situation there can be said to be worse than that of the United States.

The reason why I say this is entirely because the pharmaceutical industry in Europe is basically monopolized by several giants, such as GlaxoSmithKline in the United Kingdom, Bayer Pharmaceuticals in Germany, and Roche in Switzerland.

Basically, all pharmaceutical production in Europe is monopolized by these giants, and those small and medium-sized pharmaceutical manufacturing enterprises have no soil for survival at all, so they can only obediently give these companies as raw material suppliers.

Even if there are so many small and medium-sized pharmaceutical companies in Spain and Italy, because of their domestic protection policies, people are also good in their own countries, and it is even more difficult to acquire such pharmaceutical companies, plus Spain and Italy, such countries, the inexplicable sense of superiority over Chinese companies in China, so think about it, if you want to find a suitable small and medium-sized pharmaceutical company, it is most suitable to find it in the United States. After all, the United States has a large land area, the country's economy is also the largest in the world, and the science and technology here, especially the pharmaceutical technology, is not backward, so after thinking about it, Jin Muchen and Wang Xueming discussed it, and they also felt that it was most appropriate to find it in the United States.

Now that Scott has a recommendation, Jin Muchen certainly wants to know what kind of company he is recommending.

"Well, in fact, it's also the news that my friends and I have found out in the past two days. I've been keeping an eye on you since you told me about it the other day, but there aren't many small and medium-sized pharmaceutical companies in the United States. Mainly those large pharmaceutical companies, such as Pfizer, or Johnson, etc., and most of the other small and medium-sized pharmaceutical companies are short-lived. In the 80s of the last century, President Reagan once promoted a policy, that is, to vigorously support small and medium-sized pharmaceutical companies in the United States, that time, it can be said that it is the golden age of small and medium-sized pharmaceutical companies in the United States, in the eighties alone, the United States has emerged more than 100 small and medium-sized pharmaceutical companies, large and small, but only a dozen survived, and these dozen or so are also their own unique skills. But in the subsequent competition, these companies either gradually declined, or were swallowed up by those large pharmaceutical companies. So far, there are only five or six that have mixed well, and the one I want to recommend to you today is one of them, Amgen Pharmaceutical... ”

Before recommending it to Jin Muchen, Scott first gave Jin Muchen a general introduction to the development of small and medium-sized pharmaceutical companies in the United States, Jin Muchen was also taken aback after hearing it, he didn't know much about the domestic pharmaceutical companies in the United States, and he knew that there were only so many giants in the industry, as for small and medium-sized pharmaceutical companies, he really didn't pay much attention to them, so when he heard Scott say this, he knew that there were only so few pharmaceutical companies in the United States. (To be continued.) )